Rafferty Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-208,207
| Closed | -$8M | – | 1114 |
|
|
2023
Q2 | $8M | Buy |
208,207
+27,133
| +15% | +$1.04M | 0.05% | 279 |
|
|
2023
Q1 | $4.19M | Buy |
181,074
+7,063
| +4% | +$164K | 0.03% | 424 |
|
|
2022
Q4 | $4.56M | Buy |
174,011
+30,893
| +22% | +$809K | 0.04% | 391 |
|
|
2022
Q3 | $2.81M | Buy |
143,118
+103,816
| +264% | +$2.04M | 0.03% | 433 |
|
|
2022
Q2 | $687K | Sell |
39,302
-40,037
| -50% | -$700K | 0.01% | 749 |
|
|
2022
Q1 | $1.3M | Buy |
79,339
+13,975
| +21% | +$229K | 0.01% | 729 |
|
|
2021
Q4 | $1.07M | Buy |
65,364
+19,209
| +42% | +$313K | 0.01% | 837 |
|
|
2021
Q3 | $589K | Buy |
46,155
+20,692
| +81% | +$264K | ﹤0.01% | 1004 |
|
|
2021
Q2 | $360K | Buy |
+25,463
| New | +$360K | ﹤0.01% | 1137 |
|